AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank71
3Y CAGR+6.5%
5Y CAGR-18.0%
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

3Y CAGR
+6.5%/yr
Annual compound
5Y CAGR
-18.0%/yr
Recent acceleration
Percentile
P71
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
202561.21%
20242.00%
2023-52.42%
202250.69%
2021-24.02%
2020165.38%
2019-15.53%
2018-40.39%
2017130.92%
201614.79%